Phenotype of regenerative epithelium in idiopathic interstitial pneumonias.
The epithelial alteration in interstitial pneumonias is one of the repair processes at the sites of disease activity. Regenerative epithelial cells may participate in remodeling of the lung. To determine the phenotype of regenerative epithelial cells in usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), the expression of Clara cell 10KD protein (CC10), cytokeratin (CK) 14 and 17, surfactant apoprotein (SP)-A, KL-6/MUC1, transforming growth factor (TGF) beta2 were examined in 25 patients with UIP, 9 patients with NSIP and normal lung tissues from 10 patients with lung cancer. In honeycomb lesions of UIP, non-ciliated columnar cells mainly expressed CC10, cuboidal cells expressed CC10, CK17, CK14 and SP-A in descending order. Fibroblastic foci are covered by CK17, CK14, CC10, and a few SP-A positive flattened or cuboidal cells. Regenerative epithelium in NSIP mainly comprised cuboidal cells expressing SP-A, CC10 and CK17. KL-6 was more remarkably expressed in cuboidal and non-ciliated columnar cells both in UIP and NSIP. Expression of TGFbeta2 was observed in cuboidal and flattened epithelium. In severe fibrotic areas, CC10 expressing cells were more prominent, while SP-A positive cells were more prominent in less fibrotic areas. Regenerative epithelial cells in remodeling area in UIP may be derived from bronchiolar basal cells and Clara cells, while most of those in NSIP may be derived from type II pneumocytes. The different origin of regenerative epithelium may reflect the severity and extent of the injury and the degree of consequent fibrosis in UIP and NSIP.
Hinata
Nae
N
Department of Human Pathology, School of Medicine Tokyo Medical and Dental University, Japan.
Takemura
Tamiko
T
Ikushima
Soichiro
S
Yanagawa
Takashi
T
Ando
Tsunehiro
T
Okada
Junko
J
Oritsu
Masaru
M
Koike
Morio
M
D000941:Antigens / Q000032:analysis; D000951:Antigens, Neoplasm; D001059:Apoproteins / Q000032:analysis; D001980:Bronchi / Q000473:pathology*; D004791:Enzyme Inhibitors / Q000032:analysis; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D005347:Fibroblasts / Q000473:pathology; D005355:Fibrosis; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D007633:Keratins / Q000032:analysis; D008168:Lung / Q000166:cytology; D017563:Lung Diseases, Interstitial / Q000473:pathology*; D008175:Lung Neoplasms / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D018396:Mucin-1; D009077:Mucins / Q000032:analysis; D010641:Phenotype; D010740:Phospholipases / Q000037:antagonists & inhibitors; D011506:Proteins / Q000032:analysis; D037661:Pulmonary Surfactant-Associated Proteins / Q000032:analysis; D012038:Regeneration / Q000235:genetics; D016212:Transforming Growth Factor beta / Q000032:analysis; D053781:Transforming Growth Factor beta2; D014598:Uteroglobin
D000941:Antigens; D000951:Antigens, Neoplasm; D001059:Apoproteins; D004791:Enzyme Inhibitors; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D011506:Proteins; D037661:Pulmonary Surfactant-Associated Proteins; C556389:SCGB1A1 protein, human; C509041:TGFB2 protein, human; D016212:Transforming Growth Factor beta; D053781:Transforming Growth Factor beta2; C046616:pulmonary surfactant apoprotein; D007633:Keratins; D014598:Uteroglobin; D010740:Phospholipases